HFA
VIVO

Hoover Financial Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Hoover Financial Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$6K Hold
265
– – ﹤0.01% 534
2021
Q1 		$5K Hold
265
– – ﹤0.01% 498
2020
Q4 		$6K Buy
+265
New +$4.95K ﹤0.01% 454

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hoover Financial Advisors's VIVO Position: Q2 2021 in Review

Hoover Financial Advisors held its Meridian Bioscience Inc (VIVO) position steady in Q2 2021 at 265 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #534.

Hoover Financial Advisors first reported a position in VIVO in Q4 2020 and has held it in 3 quarters since. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

  • Hoover Financial Advisors held 265 shares of Meridian Bioscience Inc worth $6K as of Q2 2021.
  • Hoover Financial Advisors left its Meridian Bioscience Inc share count unchanged in Q2 2021.
  • Meridian Bioscience Inc made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #534 holding.
  • Hoover Financial Advisors first reported a position in Meridian Bioscience Inc in Q4 2020 and has held it in 3 quarters since.
  • 189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.